LU6471
Model Information:
Moderately differentiated SCC - pT2b, N1, pM0, V0 - complete resection
| Summary |
|
| Cancer Type |
Lung Cancer |
| Grade |
NA |
| Stage |
T2b N0 M0 |
| Ethnicity |
Western |
| Gender |
M |
| Age |
72 |
| Pathology Diagnosis |
Moderately differentiated SCC - pT2b, N1, pM0, V0 - complete resection |
| Biopsy Site |
NA |
| Treatment History |
None |
| Pathology QC |
Poorly differentiated squamous cell carcinoma (P7, P27) |
| Special Features |
Erlotinib resistant derivative of LU6411 |
| Mouse Strain |
Balb/c nu, MF-1 nu |
| TMA |
TMA-HP-LU-015 |
| Viral Status in PDX |
EBV+ (P6, RNAseq) |
| Available In |
CB_CN, CB-UK |
| RNA Seq |
P6 |
| Exome Seq |
P5 |
Growth Characteristics
Additional Characteristics
